EVIDENCE FOR ADAPTIVE AUTOREGULATORY DISPLACEMENT IN HYPOTENSIVE CORTICAL TERRITORIES ADJACENT TO ARTERIOVENOUS-MALFORMATIONS

被引:95
作者
YOUNG, WL
PILESPELLMAN, J
PROHOVNIK, I
KADER, A
STEIN, BM
JACKSON, L
TERPENNING, B
RHO, T
METZ, C
ORNSTEIN, E
OSTAPKOVICH, N
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT ANESTHESIOL,NEW YORK,NY 10032
[2] COLUMBIA UNIV COLL PHYS & SURG,DEPT NEUROL SURG,NEW YORK,NY 10032
[3] COLUMBIA UNIV COLL PHYS & SURG,DEPT RADIOL,NEW YORK,NY 10032
[4] COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT & NEUROL,NEW YORK,NY 10032
关键词
AUTOREGULATION; CEREBRAL ARTERIOVENOUS MALFORMATION; CEREBRAL BLOOD FLOW;
D O I
10.1227/00006123-199404000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WE HYPOTHESIZED THAT chronic hypotension in normal vascular territories fed by arteriovenous malformation pedicles may reset the lower limit of autoregulation and allow flow to remain constant over a lower pressure range. We studied the effect of increasing systemic mean arterial pressure (SMAP) with phenylephrine on cerebral blood flow using a novel technique. Fourteen patients undergoing 15 procedures were studied before endovascular embolization of arteriovenous malformations under neuroleptic conscious sedation. Mean pressures were transduced via a 1.5-F intracranial microcatheter, which was passed under fluoroscopic guidance into the target feeding artery. The microcatheter was positioned (unwedged) at a point that was relatively hypotensive to systemic pressure but that irrigated normal cortex on angiography; feeding mean arterial pressure (FMAP) and SMAP were recorded. A bolus of Xe-133 in saline was injected into the microcatheter, and washout was recorded for 3 minutes by a scintillation detector placed over the vascular territory of the injected pedicle. SMAP was then increased almost-equal-to 25 mm Hg by phenylephrine infusion, a second bolus was given, and washout was recorded. After exclusion of the shunt spike, initial slope was calculated. The SMAP (mean +/- standard error) increased from 65 +/- 3 to 89 +/- 2 mm Hg (P < 0.0001), and FMAP increased from 46 +/- 3 to 63 +/- 3 mm Hg (P < 0.0001); cerebral blood flow did not change (40 +/- 2 to 40 +/- 2 ml/100 g per min, P = 0.9199). Dividing the cases on the basis of the baseline FMAP into a ''severe'' hypotensive group (FMAP = 38 +/- 2; n = 7) and a ''moderate'' hypotensive group (FMAP = 54 +/- 3; n = 8), cerebral blood flow did not change in either group during phenylephrine challenge. Chronic hypotension does not necessarily result in ''vasomotor paralysis'' with loss of the ability to vasoconstrict to acute increases in perfusion pressure. Instead, it appears to displace adaptively the lower limit of autoregulation in affected vascular territories by a shift of the autoregulatory curve to the left, conceptually analogous to the adaptive displacement seen with chronic hypertension and its treatment.
引用
收藏
页码:601 / 610
页数:10
相关论文
共 47 条
  • [1] AUTOREGULATION OF CEREBRAL BLOOD FLOW - STUDIES DURING DRUG-INDUCED HYPERTENSION IN NORMAL SUBJECTS AND IN PATIENTS WITH CEREBRAL VASCULAR DISEASES
    AGNOLI, A
    FIESCHI, C
    BOZZAO, L
    BATTISTINI, N
    PRENCIPE, M
    [J]. CIRCULATION, 1968, 38 (04) : 800 - +
  • [2] Ahuja Arvind, 1993, Stroke, V24, P185
  • [3] OCCLUSIVE HYPEREMIA - A THEORY FOR THE HEMODYNAMIC COMPLICATIONS FOLLOWING RESECTION OF INTRACEREBRAL ARTERIOVENOUS-MALFORMATIONS
    ALRODHAN, NRF
    SUNDT, TM
    PIEPGRAS, DG
    NICHOLS, DA
    RUFENACHT, D
    STEVENS, LN
    [J]. JOURNAL OF NEUROSURGERY, 1993, 78 (02) : 167 - 175
  • [4] BAKAY L, 1952, SURG GYNECOL OBSTET, V95, P67
  • [5] CEREBRAL-CIRCULATION DURING ARTERIOVENOUS MALFORMATION OPERATION
    BARNETT, GH
    LITTLE, JR
    EBRAHIM, ZY
    JONES, SC
    FRIEL, HT
    [J]. NEUROSURGERY, 1987, 20 (06) : 836 - 842
  • [6] EVIDENCE OF REDISTRIBUTION OF CEREBRAL BLOOD-FLOW DURING TREATMENT FOR AN INTRACRANIAL ARTERIOVENOUS MALFORMATION
    BATJER, HH
    PURDY, PD
    GILLER, CA
    SAMSON, DS
    [J]. NEUROSURGERY, 1989, 25 (04) : 599 - 605
  • [7] THE USE OF ACETAZOLAMIDE-ENHANCED REGIONAL CEREBRAL BLOOD-FLOW MEASUREMENT TO PREDICT RISK TO ARTERIOVENOUS MALFORMATION PATIENTS
    BATJER, HH
    DEVOUS, MD
    [J]. NEUROSURGERY, 1992, 31 (02) : 213 - 218
  • [8] BOHLEN HG, 1989, J HYPERTENS, V7, pS117
  • [9] DOBERSTEIN C, 1991, J CEREB BLOOD FLO S2, V11, pS47
  • [10] DUCKWILER G, 1990, AM J NEURORADIOL, V11, P169